Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose NMN study: NAD-related metabolites and physiological aging markers
jRCT1030240368Active, not recruiting
- Sponsor
- Mirailab Bioscience
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of nicotinamide mononucleotide in Ageing, sponsored by Mirailab Bioscience. Primary endpoints: Between-group comparison of NAD-related metabolites, Between-group comparison of body composition and skin analysis and 2 more. Started May 2024; status: active, not recruiting.
02
Drugs
nicotinamide mononucleotide
03
Conditions
Ageing
Beyond the preview
Go deeper on jRCT1030240368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030240368.